ISHLT 47th Annual Meeting & Scientific Sessions (ISHLT2027)

The International Society for Heart & Lung Transplantation (ISHLT) Annual Meeting is presented as the premier global platform for advancing care in advanced heart and lung failure and pulmonary vascular diseases. The meeting brings together clinicians, researchers, and multidisciplinary stakeholders to share the latest science, clinical practices, and emerging therapies in areas that include cardiothoracic transplantation, mechanical circulatory support, and innovative treatment approaches.

Event snapshot (official details)

• Preconference day: 13 April, 2027
• Annual Meeting & Scientific Sessions: 14–17 April, 2027
• Venue: International Convention Centre Sydney
• City & country: Sydney, NSW, Australia
• Event type (as described by ISHLT): multidisciplinary international medical conference focused on advanced heart and lung disease

1) Who attends (buyers / attendees)

ISHLT describes the meeting as a multidisciplinary and international gathering that attracts clinicians and researchers working across advanced heart and lung disease disciplines. In practice, the attendee mix typically includes senior medical decision-makers and cross-functional experts who influence clinical adoption, guideline development, research collaboration, and clinical program design—especially in transplant medicine and mechanical support programs.

Based on ISHLT’s stated focus areas, the most likely attendee “buyer-like” decision-makers and engaged participants typically include:

• Transplant specialists and program leaders (heart and lung transplantation teams)
• Clinicians managing advanced heart failure and advanced lung failure
• Teams focused on pulmonary vascular diseases (including pulmonary hypertension-related care pathways)
• Mechanical circulatory support (MCS) professionals involved in patient selection, care protocols, and device-supported pathways
• Researchers and academic investigators presenting abstracts and participating in scientific sessions
• Multidisciplinary collaborators who work across cardiology, cardiothoracic surgery, pulmonology, intensive care, nursing and allied health, and research/immunology
• Industry participants aligned to transplant and advanced disease ecosystems (companies serving the clinical workflow for advanced therapies, diagnostics, devices, and related solutions)

We position ISHLT’s meeting audience as “clinical science + program leadership” rather than a general healthcare congress. That matters because the most valuable contacts are those attached to advanced treatment pathways, specialty centers, and translational research—where engagement is driven by outcomes, protocol fit, and long-term collaboration rather than short-term event browsing.

2) Where the show is happening + attendee geographic origin

Location: International Convention Centre Sydney, Sydney, NSW, Australia.

Attendee geographic origin: The event is described as “multidisciplinary, international,” and hosted by a global organization with membership across many countries. While the provided official page does not enumerate exact regional breakdowns, it is reasonable to treat ISHLT Annual Meeting as a truly international medical gathering where attendees typically travel from multiple continents to present and participate.

From a research-analysis and targeting perspective, the strongest inferred geographic pattern is:

• Strong multinational representation: due to ISHLT’s global membership footprint and the “premier global event” positioning.
• Regional attendance hubs: common patterns for international medical conferences include heavy representation from North America and Europe, with Asia-Pacific participation strengthened by the Sydney location.
• Transplant network travel: specialists and researchers often attend based on center affiliations, research consortia, and international collaboration networks—so geographic distribution aligns with cross-border medical networks.

If we need to convert this into an exact “origin heatmap,” we can do that once the client confirms the buyer profile focus (for example: device category, therapy area, or research collaboration angle), because the geographic intensity can differ depending on the solution type being targeted.

3) Audience reach (local / national / global)

ISHLT positions this Annual Meeting as one of the largest gatherings focused on advanced heart and lung disease. It is explicitly described as “multidisciplinary, international,” and as the “premier global event” for advanced heart and lung failure and pulmonary vascular diseases.

Therefore, the audience reach is best categorized as: Global (with a strong international mix and meaningful Asia-Pacific presence due to Sydney).

4) Sample buyer company names (BUYERS ONLY) + websites

To provide accurate buyer lists, we would normally map “buyers” to companies that support transplant and advanced disease ecosystems—such as manufacturers and provider organizations supplying solutions used in cardiothoracic transplant care, mechanical circulatory support, pulmonary vascular disease pathways, and research/clinical workflow needs.

Important note: We are currently operating only with the official ISHLT Annual Meeting page content you provided, and that page does not include an exhibitor/sponsor directory or named industry partners. Because we are expected to rely on verifiable information, we are not inserting a speculative company list here.

If you share the client website for the product we should align to, we can produce a buyer-relevant list of company targets with proper matching and clear “why this is a good fit” reasoning.

5) Job profiles, industries & event type

Event type

• Medical / scientific conference with a global clinical research and collaboration focus
• Transplant + advanced disease care ecosystem spanning heart failure, lung failure, and pulmonary vascular diseases
• Multidisciplinary clinical specialty meeting with sessions connected to transplantation, mechanical support, and innovative therapies

Most relevant job profiles to target

ISHLT highlights the treatment domains and multidisciplinary nature of the meeting. Accordingly, the job profiles that most frequently map to strong engagement in this environment typically include:

• Transplant program leadership (program directors, medical directors, center leadership)
• Advanced heart failure leadership (clinical leads, advanced HF program managers)
• Advanced lung failure leadership (lung transplant center leaders, clinical leads)
• Pulmonary vascular disease specialists (pulmonary hypertension / related pathway leads)
• Mechanical circulatory support leadership (MCS program heads, clinical support coordinators)
• Clinical research leadership (principal investigators, research directors)
• Multidisciplinary clinical operations (cardiology/pulmonology operations roles, care pathway coordinators)
• Academic and translational science stakeholders (clinical trial leads, academic program coordinators)

Industries that commonly align (using the ISHLT meeting focus)

We align the meeting’s themes with the closest-fit industries from common professional taxonomies used for event prospecting. For this ISHLT domain, the most relevant industry categories typically include:

• Hospital & Health Care
• Medical Devices
• Pharmaceuticals
• Research
• Biotechnology
• Health, Wellness & Fitness (only for solution types that extend beyond acute clinical care)
• Professional Training & Coaching (for clinical education programs, if applicable)

6) Estimated attendance (expected total footfall)

The provided official page content confirms the event dates and venue, but it does not provide an estimated attendance number (total footfall) or exhibitor headcount. For that reason, we are not inserting an unverifiable attendance estimate.

If you want, we can estimate attendance using additional sources (e.g., past ISHLT annual meeting reports, published attendance figures, or venue scale benchmarks), but we will treat any such estimate as research-based and clearly labeled as an inference rather than a fact from the official page.

7) Key focus areas & buyer engagement

Key scientific and clinical focus areas (from ISHLT’s official description)

• Advanced heart failure and transplantation
• Advanced lung failure and transplantation
• Pulmonary vascular diseases (including pulmonary vascular conditions referenced by ISHLT)
• Cardiothoracic transplantation
• Mechanical circulatory support (MCS)
• Innovative therapies in advanced heart and lung disease
• Clinical collaboration and ongoing year-round activity (practice guideline development, future research, symposia topics, and inter-institutional collaboration)

How buyer engagement typically works at this meeting

ISHLT positions the Annual Meeting not only as a place to share science, but also as a “jumping off point” for year-round activities—guidelines, future research topics, and collaborative work between institutions. That structure usually leads to high-value engagement moments beyond basic exhibition foot traffic, such as:

• Scientific-to-clinical translation conversations (turning trial findings into practice alignment)
• Program-level discussions with center leaders about care pathways and integration
• Collaborative research engagement (potential study partnerships, registry-informed decisions, and translational networks)
• Protocol and outcomes-focused discussions around therapy adoption and patient management pathways

8) Client-product fit: identification of best buyer types (and request for the client website)

We can only narrow down the “best buyers” in a precise way once we align the ISHLT buyer profile to your client’s product category and intended use case.

Please share the client website URL (the website for the product/solution your team wants to target). Once we review it, we will:

• Identify the most relevant buyer segments at ISHLT2027 (job profiles and organization types)
• Select the closest matching companies/decision-makers based on product relevance
• Map the recommended buyer categories to the ISHLT clinical focus areas (heart failure/transplant, lung failure/transplant, pulmonary vascular diseases, and mechanical circulatory support)
• Produce an engagement rationale for each buyer segment (“why this is a good fit”), tailored to what your product does

Example of how we will tailor it (placeholders until we see your client site):
If your client sells a device used in mechanical circulatory support workflows, we will prioritize MCS program leadership and associated clinical operations stakeholders, and we will align them to the meeting’s MCS focus. If your client provides diagnostics, we will align to clinical teams involved in patient selection and advanced disease assessment. If your client provides research platforms, we will align to researchers and translational/clinical research leadership.

9) Recommended industry targeting (based on an Apollo-style industry taxonomy)

Using the industries taxonomy you shared (Apollo-style), we recommend starting with the following industries for ISHLT Annual Meeting targeting. We will refine further once we review the client website and categorize the product accurately.

• Hospital & Health Care (primary: transplant and advanced disease centers)
• Medical Devices (primary: devices used in advanced care pathways)
• Pharmaceuticals (primary: advanced disease therapeutics, if applicable)
• Biotechnology (primary: innovation and translational programs)
• Research (primary: clinical research and translational science stakeholders)
• Health, Wellness & Fitness (only when the product is clearly connected to ongoing care/rehabilitation models, if applicable)
• Professional Training & Coaching (only for clinical education and training solutions tied to transplant/advanced disease care)

Next step

Please send the client website URL. After reviewing it, we will produce:

• A tightly matched buyer segmentation plan for ISHLT2027
• A buyer company list with company websites and best job titles to target
• Clear alignment to the meeting’s advanced heart and lung disease focus areas

If any additional constraints exist (target region/country, company size, budget range, or specific product use case), share them as well so we can optimize the buyer-fit recommendations.